Related Experiment Video
Updated: Aug 19, 2026

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
Published on: February 26, 2014
Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes
Yiliang Zhu1, Michael R Wessel, Tiebin Liu
1Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL 33612, USA. yzhu@hsc.usf.edu
Abstract:
Neurotoxic effects are a non-cancer endpoint for health risk, and neurobehavioral screening tests can serve as a first tier investigation of neurotoxicity [US EPA, Federal Register 63 (1998) 26926]. Analysis of neurobehavioral screening data such as those of the functional observational battery (FOB) traditionally relies on analysis of variance (ANOVA). ANOVA is designed to detect whether there are dose-effects, but does not model the underlying dose-response relationship and subsequent risk assessment fails to utilize the shape of the underlying dose-response. In contrast, dose-response modeling interpolates toxic effects between experimental points, and permits prediction of toxic effects within the experimental range. Additionally it is also a prerequisite for estimating a benchmark dose. This paper discusses dose-time-response modeling of longitudinal neurotoxicity data and illustrates the methods using three continuous FOB outcomes from an EPA study involving acute exposure to triethyltin (TET). Several mathematical functions are presented as candidate dose-time-response models. The use of random effects is discussed to characterize inter-subject variation. The results indicate that it is feasible to use simple mathematical functions to model empirical dose-time-response observed in existing longitudinal neurotoxicological data. Further research is needed on the types of design and data required to reliably approximate the true underlying dose-time-response.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Dose Response Curve: Conventional Versus Nonmonotonic
Analysis of Population Pharmacokinetic Data